A new study reveals that the popular diabetes and weight-loss drug Ozempic might hold the key to relieving chronic migraines, ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, researchers in Italy have found.

The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the placebo effect, researchers said.

The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

Ozempic-like drug significantly reduces frequency of chronic migraines in pilot study by Krystal Kasal, Phys.org edited by Gaby Clark, reviewed by Robert Egan Editors' notes ...

Already a household name in diabetes and weight management, Ozempic (semaglutide) may soon find another surprising role — as ...

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this widespread impact, many sufferers find current preventive treatments ...

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say liraglutide, a GLP-1RA, might help migraine by reducing intracranial ...